References
- Davis P, Miller C L, Russel AS. Effects of gold compounds on the function of phagocytic cells. I. Suppression of phagocytosis and the generation of chemiluminescence by polymorphonuclear leukocytes. J Rheumatol 1982; 9: 18–24, suppl. 8
- Hafström I, Udén A-M, Palmblad J. Modulation of neutrophil functions by auranofin. Scand J Rheumatol 1983; 12: 97–105
- Davis P, Johnston C, Miller C L, Wong K. Effects of gold compounds on the function of phagocytic cells. II. Inhibition of superoxide radical generation by tripeptide-activated polymorphonuclear leukocytes. Arthritis Rheum 1983; 26: 82–6
- Minta J O, Williams MD. Interactions of antirheumatic drugs with the superoxide generation system of activated human polymorphonuclear leukocytes. J Rheumatol 1986; 13: 498–504
- Finkelstein A E, Roisman F R, Ladizesky M G, Walz DT. Auranofin and lysosomal enzymes. J Rheumatol 1982; 9: 46–53, suppl. 8
- Pedersen B K, Äbom B. Characterization of the in vitro effect of triethylphosphine gold (auranofin) on human NK cell activity. Clin Exp Rheumatol 1986; 4: 249–53
- Crooke S T, Mirabelli CK. Molecular mechanism of action of auranofin and other gold complexes as related to their biologic activities. Am J Med 1983; 75: 109–13
- Waltz D T, Griswold D E, Di Martino M J, Bumbier EE. Distribution of gold in blood following administration of auranofin (SK & FD-39162). J Rheumatol 1979; 6: 56–60, Suppl. 5
- Beccerica E, Piergiacomi G, Curatola G, Ferretti G. Changes of lymphocyte membrane fluidity in rheumatoid arthritis: a fluorescence polarization study. Ann Rheum Dis 1988; 47: 472–7
- Spiegelberg H, Dainer P. Fc receptors for IgG, IgM and IgE on human leukemic lymphocytes. Clin Exp Immunol 1979; 35: 286–95
- Shinitzky M. Membrane fluidity and cellular functions. Physiology of membrane fluidity, M Shinitzky. CRC Press, Boca Raton, Florida 1984; 1–52
- Hafström I, Seligmann B E, Friedmann M M, Gallin JI. Auranofin affects early events in human polymorphonuclear neuthrophil activation by receptor-mediated stimuli. J Immunol 1984; 132: 2007–14
- Lorber A, Jackson W H, Simon TM. Effects of chrysotherapy on cell mediated immune response. J Rheumatol 1982; 9: 37–45, suppl. 8
- Sharma R P, Smillie J, Palmer DG. Gold concentrations and toxicity during oral gold treatment with auranofin. Pharmacology 1985; 30: 115–20
- van Riel P LCM, Gribnau F WJ, Van De Putte L BA, Arts C WMM, van Aernsbergen A. Serum gold concentrations during treatment with auranofin. Clin Rheumatol 1987; 6: 50–4
- Finkelstein A E, Roisman F R, Batista V, de Nudelman F G, de Titto E H, Mizraji M, Walz DT. Oral chrysotherapy in rheumatoid arthritis: minimum effective dose. J Rheumatol 1980; 7: 160–8
- Johnson D A, Lee N M, Cooke R, Loh HH. Ethanol-induced fluidization of brain lipid bilayer: required presence of cholesterol in membrane for the expression of tolerance. Mol Pharmacol 1979; 15: 739–46
- Miller K W, Pang KY. General anaesthetics can selectively perturb lipid bilayer membranes. Nature 1976; 263: 253–5
- Brunk U, Cadenas E. The potential intermediate role of lysosomes in oxygen free radical pathology. Acta Pathol Microbiol Scand 1988; 96: 3–13
- Richter C. Biophysical consequences of lipid peroxidation in membranes. Chem Phys Lipid 1987; 44: 175–89